- Lobbying
- medicines
Lobbying Arrangements Results for 'Medicines'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details - Issues relating to the labeling of generic drugs. - Issues relating to the 180 day exclusivity for generics. - Issues related to medical supply chain, including supply chain safety. - Issues rela... |
Association for Accessible Medicines (Formerly Generic Pharmaceutical Assoc.)
|
CAPITOL HILL CONSULTING GROUP | |||
Details Educate policymakers on pharmacy issues related to TRICARE and H.R. 2670, S.2226 Fiscal Year 2024 National Defense Authorization Act; issues related to removing barriers to biosimilar medicine acce... |
CIGNA Corporation
|
Invariant LLC | |||
Details Health care reform; drug safety, value and reimbursement; prevention, diagnosis and treatment of chronic disease; implementation of related provisions in the Affordable Care Act; value of prescript... |
Sanofi US Services Inc.
|
Capitol Counsel LLC | |||
Details H.R. 6363 Further Continuing Appropriations and Other Extensions Act of 2024 H.R. 5378 the Lower Costs, More Transparency Act S.3548 - Health Care Prices Revealed and Information to Consumers E... |
KAISER FOUNDATION HEALTH PLAN INC.
|
in-house lobbying | |||
Details H.R. 501, the Block, Report, and Suspend Suspicious Shipments Act; S. 2666, the E-Prescribing Parity for Controlled Substances Act Remote Prescribing of Controlled Substances H.R. 1613 / S. 1038, t... |
National Community Pharmacists Association
|
in-house lobbying | |||
Details Affordable Care Act (ACA), ACA subsidies; Telehealth; Mental Health, Mental Health Rule, Youth Mental Health Access; Site Neutrality/Site neutral payment reform and Fair Hospital Billing; Transpare... |
Blue Cross and Blue Shield of Kansas, Inc.
|
in-house lobbying | |||
Details Issues related to corporate taxation including R & D tax deductions and expense amortization, and deductibility of business interest. H.R. 5376, Inflation Reduction Act of 2022. Tax Extender legisl... |
Genentech, Inc.
|
Harbinger Strategies, LLC | |||
Details Medicare Part D coverage and patient access policies ESRD bundling and drug reimbursement issues HCPCS coding and reimbursement decisions Implementation of Patient Protection & Affordable Health Ca... |
GENZYME CORPORATION
|
in-house lobbying | |||
Details deficit reduction, debt ceiling, appropriations H.R. 4378 - Continuing Appropriations Act and Health Extenders Act H.R. 1865 - Further Consolidated Appropriations Act, 2020 H.R. 3055 - Further Cont... |
Pfizer
|
TARPLIN, DOWNS & YOUNG, LLC | |||
Details Provider Directories; Medicaid Redeterminations; Draft Duals Legislation; IRA Copay Smoothing; MA Health Equity Index HR 2880 (118th Congress), Protecting Patients Against PBM Abuses Act, by Rep. ... |
GuideWell Mutual Holding Corporation
|
in-house lobbying | |||
Details H.R. 3, (117th Cong.) Elijah E. Cummings Lower Drug Costs Now Act H.R. 19, (117th Cong.) Lower Costs, More Cures Act of 2021 H.R. 830, Help Ensure Lower Patient (HELP) Copays Act H.R. 1503/S. 2916,... |
Merck & Co, Inc.
|
in-house lobbying | |||
Details Issues related to: - Contact lens safety, peripheral artery disease, and stroke care, specifically to provisions regarding appropriations report language - Appropriations for Labor Health and Human... |
JOHNSON & JOHNSON SERVICES, INC.
|
in-house lobbying | |||
Details FDA modernization policy issues Reauthorization of newborn screening programs General issues related to rare disease and orphan drugs General issues related to health equity in rare disease and ... |
AstraZeneca Pharmaceuticals LP
|
in-house lobbying | |||
Details Opioid Abuse - General issues related to opioid abuse and access to medication assisted treatment HR 1770/S. 2477 - Equitable Community Access to Pharmacist Services Act Implementation of Public L... |
Healthcare Distribution Alliance (Healthcare Distribution Managment Assn.)
|
TARPLIN, DOWNS & YOUNG, LLC | |||
Details Medicaid Disproportionate Hospital (DSH) payment cuts - Urged Congress to avoid Medicaid Disproportionate Share Hospital (DSH) payment cuts scheduled to begin in FY 2024. Urged passage of Supportin... |
Vizient, Inc.
|
in-house lobbying | |||
Details Affordable Care Act (ACA); ACA Subsidies; Telehealth; Mental Health; Mental Health Rule; Youth Mental Health Access; Site Neutrality/Site Neutral Payment Reform and Fair Hospital Billing; Transpare... |
Blue Cross and Blue Shield of Florida, Inc.
|
in-house lobbying | |||
Details Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutriti... |
American Cancer Society Cancer Action Network, Inc.
|
in-house lobbying | |||
Details S 462 Mental Health Professionals Workforce Shortage Loan Repayment Act: increasing the mental health workforce HR 1423 911 Community Crisis Responders Act- Increasing the number of unarmed menta... |
National Alliance on Mental Illness
|
in-house lobbying | |||
Details Affordable Care Act (ACA), ACA subsidies; Telehealth; Mental Health, Mental Health Rule, Youth Mental Health Access; Site Neutrality/Site neutral payment reform and Fair Hospital Billing; Transpare... |
BLUE CROSS BLUE SHIELD OF MICHIGAN
|
in-house lobbying | |||
Details Insulin Out of Pocket Costs; Covid Therapeutics; Generics Access; Gene Therapy S. 150 - Affordable Prescriptions for Patients Act of 2023 A bill to amend the Federal Trade Commission Act to prohi... |
Blue Cross and Blue Shield Association
|
in-house lobbying | |||
Details RetireSafe joined with the National Energy and Utility Affordability Coalition to urge the House and Senate Appropriations Committees to support at least $4.7 billion for the FY 2016 Low Income Hom... |
RetireSafe
|
Mr. ALFRED W. CORS, JR | |||
Details H.R. 4368: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 5893: Commerce, Justice, Science, and Related Agencies Appropriations Act... |
GSK (fka GLAXOSMITHKLINE INC.)
|
in-house lobbying | |||
Details H.R. 4368: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 5893: Commerce, Justice, Science, and Related Agencies Appropriations Act... |
Pharmaceutical Research and Manufacturers of America
|
in-house lobbying | |||
Details H.R. 485 - Protecting Health Care For All Patients Act of 2023 - Rep. McMorris Rodgers, Cathy - federal programs using prices based on quality-adjusted life years H.R. 824 - Telehealth Benefit Exp... |
AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)
|
in-house lobbying |